Initial studies in T cells postulated that the C-terminal region of GATA3, between residues 261 and 315, is critical for proteasomal degradation [31], and further work in ER-positive breast cancer cells subsequently identified serine residue 308 as the critical site [29]. The gene discussed is GATA3; the disease is breast carcinoma.